top of page
Shionogi Further Extends Infectious Disease Innovation Platform with Planned Acquisition of Qpex Biopharma, Inc.
Acquisition brings access to a novel investigational ß-lactamase inhibitor, expanding pipeline of critically needed antimicrobials, and further augments R&D capabilities and expertise.
bottom of page